MPO and coronary artery disorder: Targeting MPO has the potential to become one of the most promising therapies for coronary heart disease and other atherosclerotic cardiovascular diseases, such as PF-06282999 (8), which has effective and selective MPO inhibition properties, and has been advanced into clinical trials in human pharmacokinetics, safety, tolerance, and MPO inhibition studies (30).